Summit Therapeutics
Clinical trials sponsored by Summit Therapeutics, explained in plain language.
-
New cancer drug trial challenges standard treatment
Disease control Recruiting nowThis study compares two different drug combinations for people newly diagnosed with advanced colorectal cancer that has spread. About 600 participants will receive either a new drug called ivonescimab or the standard drug bevacizumab, both combined with chemotherapy. The goal is …
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Major trial tests new drug combo against standard treatment for advanced lung cancer
Disease control Recruiting nowThis study compares two different drug combinations for people with advanced non-small cell lung cancer that has spread. About 1600 participants will receive either a new drug called ivonescimab or the standard drug pembrolizumab, both combined with chemotherapy. The main goals a…
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New drug challenges standard treatment in major lung cancer trial
Disease control Recruiting nowThis large Phase 3 trial is testing whether a new immunotherapy drug called ivonescimab works better than the current standard drug (pembrolizumab) for people with advanced non-small cell lung cancer that has spread and shows high levels of a specific marker called PD-L1. The stu…
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC